Division of Pulmonary Diseases, Department of Medical Specialties, Geneva University Hospitals, Geneva, Switzerland,
Department of Community Medicine, Primary Care, and Emergency, Geneva University Hospitals, Geneva, Switzerland.
Respiration. 2019;97(5):406-415. doi: 10.1159/000495312. Epub 2019 Jan 16.
Despite their poor prognosis, patients with severe chronic obstructive pulmonary disease (COPD) have little access to palliative care and tend to have a high rate of hospital and intensive care unit (ICU) admissions during their last year of life.
To determine the feasibility of a home palliative care intervention during 1 year versus usual care, and the possible impact of this intervention on emergency, hospital and ICU admissions, survival, mood, and health-related quality of life (HRQL).
Prospective controlled study of patients with severe COPD (GOLD stage III or IV) and long-term oxygen therapy and/or home noninvasive ventilation and/or one or more hospital admissions in the previous year for acute exacerbation, randomized to usual care versus usual care with add-on monthly intervention by palliative care specialists at home for 12 months.
Of 315 patients screened, 49 (15.5%) were randomized (26 to early palliative care; 23 to the control group); aged (mean ± SD) 71 ± 8 years; FEV1 was 37 ± 14% predicted; 88% with a COPD assessment test score > 10; 69% on long-term oxygen therapy or home noninvasive ventilation. The patients accepted the intervention and completed the assessment scales. After 1 year, there was no difference between groups in symptoms, HRQL and mood, and there was a nonsignificant trend for higher admission rates to hospital and emergency wards in the intervention group.
Although this pilot study was underpowered to formally exclude a benefit from palliative care in severe COPD, it raises several questions as to patient selection, reluctance to palliative care in this group, and modalities of future trials.
尽管患有严重慢性阻塞性肺疾病(COPD)的患者预后较差,但他们很少接受姑息治疗,并且在生命的最后一年往往有很高的住院和重症监护病房(ICU)入院率。
确定在 1 年内进行家庭姑息治疗干预与常规护理相比的可行性,以及该干预对急诊、住院和 ICU 入院、生存、情绪和健康相关生活质量(HRQL)的可能影响。
对患有严重 COPD(GOLD 阶段 III 或 IV)、长期氧疗和/或家庭无创通气和/或在过去一年因急性加重而住院的患者进行前瞻性对照研究,随机分为常规护理组和常规护理组,常规护理组在 12 个月内每月接受姑息治疗专家的家庭附加干预。
在筛选的 315 名患者中,有 49 名(15.5%)被随机分配(26 名接受早期姑息治疗;23 名进入对照组);年龄(平均值±标准差)为 71±8 岁;FEV1 为预计值的 37±14%;88%的患者 COPD 评估测试评分>10;69%的患者接受长期氧疗或家庭无创通气。患者接受了干预并完成了评估量表。1 年后,两组在症状、HRQL 和情绪方面没有差异,干预组的住院和急诊病房入院率有升高的趋势,但无统计学意义。
尽管这项初步研究的效力不足以正式排除姑息治疗对严重 COPD 的益处,但它提出了一些问题,例如患者选择、该组对姑息治疗的不情愿以及未来试验的模式。